tiprankstipranks
Trending News
More News >
Supernus Pharmaceuticals (SUPN)
:SUPN
US Market

Supernus Pharmaceuticals (SUPN) Balance Sheet

Compare
503 Followers

Supernus Pharmaceuticals Balance Sheet

Supernus Pharmaceuticals's total assets for Q1 2025 were $1.35B, a decrease of -1.52% from the previous quarter. SUPN total liabilities were $316.58M for the fiscal quarter, a -4.74% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 1.37B$ 1.28B$ 1.70B$ 1.69B$ 1.50B
Total Liabilities
$ 332.34M$ 356.16M$ 816.30M$ 873.30M$ 759.24M
Total Equity Gross Minority
$ 1.04B$ 921.52M$ 886.20M$ 815.85M$ 744.86M
Other Metrics
Currency in USD

Supernus Pharmaceuticals Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis